Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
J Korean Epilepsy Soc. 2002 Jun;6(1):20-26. Korean. Original Article.
Kim OJ , Kim NK , Kim HJ , Seo JH , Lee GY , Choi BO , Ahn JY , Oh DY , Kim SH .
Department of Neurology, College of Medicine, Pochon CHA University, Kyonggi-do, Korea. okjun77@cha.ac.kr
Institute for Clinical Research, College of Medicine, Pochon CHA University, Kyonggi-do, Korea.
Department of Diagnostic radiology, College of Medicine, Pochon CHA University, Kyonggi-do, Korea.
Abstract

PURPOSE: Hyperhomocysteinemia was observed in epileptic patients receiving anticonvulsants, especially homozygotes for mtehylenetetrahydrofolate reductase (MTHFR) gene 677C->T mutation. Hyperhomocysteinemia induce atherosclerosis, fetal anticonvulsant syndrome, etc. Therefore, we examined any other factors that might affect the level of homocysteine in epileptic patients. METHODS: We investigated the plasma total homocysteine level in 145 patients with epilepsy. And then we analyzed various factors (clinical findings, neuro-image finding, drugs, MTHFR gene, serum folate and vitamin B12 level) affecting the level of homocysteine. RESULTS: Among the various factors, male, present neurological deficits, frequent seizure attacks, MTHFR gene 677 TT genotype, polypharmacy, and conventional drug (phenytoin, carbamazepine, valproic acid, phenobarbital, primidone, benzodiazpines) than new drug (lamotrigine, vigabatrin, topiramate, oxcarbazepine zonisamide) were related with elevated homocysteine levels. CONCLUSION: We recommend monotherapy with new drugs and higher vitamin requirement in the male epileptic patients of MTHFR TT genotype with neurological deficits and frequent seizure attacks.

Copyright © 2019. Korean Association of Medical Journal Editors.